The development of innovative radiotherapy by inhibiting IL-6 signaling for refractory oral cancer eradication
Project/Area Number |
18H03005
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Review Section |
Basic Section 57060:Surgical dentistry-related
|
Research Institution | Kumamoto University |
Principal Investigator |
Nakayama Hideki 熊本大学, 大学院生命科学研究部(医), 教授 (70381001)
|
Project Period (FY) |
2018-04-01 – 2021-03-31
|
Project Status |
Completed (Fiscal Year 2020)
|
Budget Amount *help |
¥17,550,000 (Direct Cost: ¥13,500,000、Indirect Cost: ¥4,050,000)
Fiscal Year 2020: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Fiscal Year 2019: ¥5,850,000 (Direct Cost: ¥4,500,000、Indirect Cost: ¥1,350,000)
Fiscal Year 2018: ¥9,230,000 (Direct Cost: ¥7,100,000、Indirect Cost: ¥2,130,000)
|
Keywords | IL-6 / 放射線療法 / 口腔扁平上皮癌 / 放射線耐性 / IL-6シグナル / がん微小環境 / 口腔癌 / 治療抵抗性 |
Outline of Final Research Achievements |
X-ray irradiation under tocilizumab treatment in OSCC xenograft and PDX in vivo models demonstrated that tocilizumab augments the effect of X-ray irradiation and attenuates the level of radiation-induced dermatitis. It is likely that the effects of tocilizumab are brought about by reduced antioxidant activity of Nrf2-antioxidant pathway and decreased IL-6 expression. Radiotherapy under the treatment of tocilizumab can be largely expected to clinically apply in OSCC patients as a promising novel therapy.
|
Academic Significance and Societal Importance of the Research Achievements |
OSCCに対するトシリズマブ併用の放射線療法の開発は世界発の試みである。トシリズマブは安全性や体内動態が確認された既存薬であり、ドラッグリポジショニングで臨床応用を図ることは、新薬の開発と比べてコスト面で大きな利点となる。放射線治療時にトシリズマブを同時に投与することにより、放射線の抗腫瘍効果を増強し、口腔粘膜炎や皮膚炎を軽くできることから、本研究結果は学術的・社会的に大きな意義を有する。
|
Report
(4 results)
Research Products
(36 results)
-
[Journal Article] Colonization of distant organs by tumor cells generating circulating homotypic clusters adaptive to fluid shear stress2021
Author(s)
Maeshiro M, Shinriki S, Liu R, Nakachi Y, Komohara Y, Fujiwara Y, Ohtsubo K, Yoshida R, Iwamoto K, Nakayama H, Matsui H.
-
Journal Title
Sci Rep
Volume: 11
Issue: 1
Pages: 6150-6150
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
-
-
-
[Journal Article] Efficacy of adjuvant chemotherapy with S-1 in stage II oral squamous cell carcinoma patients: A comparative study using the propensity score matching method2020
Author(s)
Ryoji Yoshida, Masashi Nagata, Akiyuki Hirosue, Kenta Kawahara, Masafumi Nakamoto, Masatoshi Hirayama, Nozomu Takahashi, Yuichiro Matsuoka, Junki Sakata, Hikaru Nakashima, Hidetaka Arita, Akimitsu Hiraki, Masanori Shinohara, Ken Kikuchi, Hideki Nakayama
-
Journal Title
PLoS One
Volume: 15
Issue: 4
Pages: e0231656-e0231656
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Enhanced Expression of IGFBP-3 Reduces Radiosensitivity and Is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma2020
Author(s)
Sakata J, Hirosue A, Yoshida R, Matsuoka Y, Kawahara K, Arita H, Nakashima H, Yamamoto T, Nagata M, Kawaguchi S, Gohara S, Nagao Y, Yamana K, Toya R, Murakami R, Kuwahara Y, Fukumoto M, Nakayama H
-
Journal Title
Cancers (Basel)
Volume: 12(2)
Issue: 2
Pages: 494-494
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
[Journal Article] Diagnostic Value of FDG-PET/CT for the Identification of Extranodal Extension in Patients With Head and Neck Squamous Cell Carcinoma2020
Author(s)
Toya, R. Saito, T. Matsuyama, T. Kai, Y. Shiraishi, S. Murakami, D. Yoshida, R. Watakabe, T. Sakamoto, F. Tsuda, N. Arimura, H. Orita, Y. Nakayama, H. Oya, N.
-
Journal Title
Anticancer Res
Volume: 40
Issue: 4
Pages: 2073-2077
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Enhancement of cancer invasion and growth via the C5a-C5a receptor system: Implications for cancer promotion by autoimmune diseases and association with cervical cancer invasion.2019
Author(s)
Yoneda M, Imamura R, Nitta H, Taniguchi K, Saito F, Kikuchi K, Ogi H, Tanaka T, Katabuchi H, Nakayama H, Imamura T.
-
Journal Title
Oncol Lett.
Volume: 17
Pages: 913-20
DOI
Related Report
Peer Reviewed
-
[Journal Article] Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study2019
Author(s)
Nakashima H, Yoshida R, Hirosue A, Kawahara K, Sakata J, Arita H, Yamamoto T, Toya R, Murakami R, Hiraki A, Shinohara M, Ito T, Kuwahara Y, Nakayama H
-
Journal Title
Tumour Biol
Volume: 41(3)
Issue: 3
Pages: 1-10
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
[Journal Article] Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma2018
Author(s)
Shinriki S, Jono H, Maeshiro M, Nakamura T, Guo J, Li JD, Ueda M, Yoshida R, Shinohara M, Nakayama H, Matsui H, Ando Y.
-
Journal Title
Journal of Pathology
Volume: 244
Issue: 3
Pages: 367-379
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] 口腔扁平上皮癌におけるトシリズマブの放射線感受性効果の検討(Investigation of the effect of tocilizumab on radiosensitivity in oral squamous cell carcinoma)2018
Author(s)
有田 英生, 吉田 遼司, 松岡 祐一郎, 廣末 晃之, 永田 将士, 川原 健太, 坂田 純基, 中嶋 光, 川口 翔, 郷原 俊輔, 永尾 優果, 山名 啓介, 中山 秀樹
Organizer
日本癌学会
Related Report
-
[Presentation] IL-6はマウス由来の口腔扁平上皮癌細胞株において、放射線抵抗性に関与する(Interleukin-6 confers radioresistance phenotype on Sq-1979 cells: mouse-derived oral squamous cell carcinoma cell line)2018
Author(s)
山名 啓介, 吉田 遼司, 坂田 純基, 松岡 祐一郎, 川原 健太, 有田 英生, 中嶋 光, 廣末 晃之, 川口 翔, 郷原 俊輔, 永尾 優果, 中山 秀樹
Organizer
日本癌学会
Related Report
-
[Presentation] 抗酸化ストレス調節因子Nrf2は口腔扁平上皮癌の放射線耐性を制御する(Nrf2, anti-oxidative stress-regulatory factor, controls resistance to radiation in oral squamous cell carcinoma)(英語)(2018
Author(s)
松岡 祐一郎, 吉田 遼司, 廣末 晃之, 永田 将士, 川原 健太, 坂田 純基, 有田 英生, 中嶋 光, 平木 昭光, 篠原 正徳, 中山 秀樹
Organizer
日本癌学会
Related Report
-
[Presentation] 口腔扁平上皮癌におけるIL-6、IL-6Rシグナリングによる放射線感受性効果の有用性2018
Author(s)
有田 英生, 吉田 遼司, 松岡 祐一郎, 廣末 晃之, 永田 将士, 川原 健太, 中嶋 光, 坂田 純基, 郷原 俊輔, 永尾 優果, 川口 翔, 山名 啓介, 中山 秀樹
Organizer
日本口腔科学会
Related Report